IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 367

India’s cumulative vaccination coverage crosses 157.91 crore. More than 68 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 157.91 Crore (1,57,91,63,478) today. More than 68 lakh (68,95,050) Vaccine Doses have been administered till 7 pm today. More than 50 lakh (50,56,277) Precaution Doses for the identified categories of beneficiaries for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10390483
2nd Dose 9785198
Precaution Dose 1982194
FLWs 1st Dose 18389193
2nd Dose 17066517
Precaution Dose 1676311
Age Group 15-18 years 1st Dose 35737355
Age Group 18-44 years 1st Dose 526753338
2nd Dose 371874157
Age Group 45-59 years 1st Dose 197841344
2nd Dose 161792292
Over 60 years 1st Dose 123259762
2nd Dose 101217562
Precaution Dose 1397772
Cumulative 1st dose administered 912371475
Cumulative 2nd dose administered 661735726
Precaution Dose 5056277
Total 1579163478

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 17th January, 2022 (367th Day)
HCWs 1st Dose 196
2nd Dose 4375
Precaution Dose 147815
FLWs 1st Dose 199
2nd Dose 10653
Precaution Dose 193232
Age Group 15-18 years 1st Dose 1170713
Age Group 18-44 years 1st Dose 1235179
2nd Dose 2491646
Age Group 45-59 years 1st Dose 174811
2nd Dose 711814
Over 60 years 1st Dose 105767
2nd Dose 385186
Precaution Dose 263464
Cumulative 1st dose administered 2686865
Cumulative 2nd dose administered 3603674
Precaution Dose 604511
Total 6895050

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker